iSpecimen shares surge 15.91% after-hours after completing SalesStack digital transformation milestone with live AI-powered marketplace launch.
ByAinvest
Friday, Feb 6, 2026 4:01 pm ET1min read
ISPC--
iSpecimen Inc. (NASDAQ: ISPC) surged 15.91% in after-hours trading following the announcement of completing Milestone 2 in its SalesStack digital transformation, which includes a fully integrated live marketplace connecting customer requests with supplier inventories. The update enabled streamlined operations, cost reductions, and AI-driven matching capabilities, positioning the company for scalable growth. Additionally, the firm reported rapid procurement of 500 influenza swab samples for a customer research project, demonstrating operational agility and reinforcing client confidence in its biospecimen sourcing capabilities. These developments underscore progress in digital infrastructure and service reliability, aligning with the stock’s sharp post-market gain.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet